"In vitro" differences among (R) and (S) enantiomers of profens in their activities related to articular pathophysiology

Inflammation

Volumn 29, Issue 4-6, 2005, Pages 119-128

  Panico, A M ^a   Cardile, V ^a   Gentile, B ^a   Garufi, F ^a   Avondo, S ^a   Ronsisvalle, S ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Arthritis; Chondrocytes; IL 1 ; Profens

Indexed keywords

FLURBIPROFEN; GLYCOSAMINOGLYCAN; INTERLEUKIN 1BETA; KETOPROFEN; NITRIC OXIDE; NITRITE; NONSTEROID ANTIINFLAMMATORY AGENT; PROPIONIC ACID DERIVATIVE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; REACTIVE OXYGEN METABOLITE; STROMELYSIN;

ARTHRITIS; ARTHROPATHY; ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG INDICATION; DRUG SPECIFICITY; ENANTIOMER; HUMAN; HUMAN CELL; IN VITRO STUDY; RACEMIC MIXTURE; STEREOSPECIFICITY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARTILAGE, ARTICULAR; CELL SURVIVAL; CELLS, CULTURED; CHONDROCYTES; DINOPROSTONE; FEMUR HEAD; FLURBIPROFEN; GLYCOSAMINOGLYCANS; HUMANS; INTERLEUKIN-1BETA; KETOPROFEN; MATRIX METALLOPROTEINASE 3; NITRITES; REACTIVE OXYGEN SPECIES; STEREOISOMERISM;

EID: 33845416419     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10753-006-9003-1     Document Type: Article

References (27)

1. Bullogh, P. G. 1998. In: Rheumatology, J. H. Klippel and P. A. Dieppe, eds. Mosby-Year Book Europe Limited, London, 7:1-7.8.
2. Blanco, F. J., R. L. Ochs, H. Schwartz, and M. Lotz. 1995. Chondrocyte apoptosis induced by nitric oxide. Am. J. Pathol. 146:75-85.
3. Geng, Y., J. Valbracht, and M. Lotz. 1996. Selective activation of the mitogen-activated protein kinase subgroups c-Jun NH2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes. J. Clin. Invest. 98:2425-2430.
4. Evans, C. H., and M. Stefanovic-Racic. 1996. Nitric oxide in arthritis. Methods 10:38-42.
5. Hassan, M. S., M. M. Mileva, H. S. Dweck, and L. Ronsenfeld. 1998. Nitric oxide products degrade chondroitin sulfates. Nitric Oxide 2:360-365.
6. Moncada, S., R. M. Palmer, and E. A. Higgs. 1991. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142.
7. Bernardeau, C., E. Dernis-Labous, H. Blanchard, D. Lamarque, and M. Breban. 2001. Nitric oxide in rheumatology. Jt. Bone Spine 68:457-462.
8. Nedelec, E., A. Abid, C. Cipolletta, N. Presle, B. Terlani, P. Netter, and J. Y. Jouzeau. 2001. Stimulation of cyclooxygenase-2-activity by nitric oxide-derived species in rat chondrocyte: lack of contribution to loss of cartilage anabolism. Biochem. Pharmacol. 61:965-978.
9. Sapolsky, A., H. Kaiser, D. S. Howell, and J. F. Woesser. 1976. Metalloproteinases of human articular cartilage that digest cartilage proteoglycan at neutral and acid. Ph. J. Clin Invest. 58: 1030-1041.
10. Smith, C., Y. Zhang, C. M. Koboldt, J. Muhammad, B. S. Zweifel, A. Shaffer, J. Talley, J. L. Mansferr, and K. Siebert. 1998. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc. Natl. Acad. Sci. USA. 95:13313-13318.
11. Henrotin, Y. E., P. Bruckner, and J. P. Pujol. 2003. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthr. Cartil. 11:747-755.
12. Dingle, J. T. 1999. The effects of NSAID on the matrix of human articular cartilages. Z. Rheumatol. 58:125-129.
13. Dingle, J. 1993. Prostaglandins in human cartilage metabolism. J. Lipid. Mediat. 6:303-312.
14. Di Battista, J., S. Dore, J. Martel-Pellettier, and J. P. Pelletier. 1996. Prostaglandin E2 stimulates incorporation of proline into collagenase digestible proteins in human articular chondrocytes: identification of an effector autocrine loop involving insulin-like growth factor I. J. Mol. Cell. Endocrinol. 123:27-35.
15. Carabaza, A., F. Cabre, E. Rotllan, M. Gomez, M. Gutierrez, M. L. Garcia, and D. Mauleon. 1996. Stereoselective inhibition of inducible cyclooxygenase by chiral nonsteroidal antiinflammatory drugs. J. Clin. Pharmacol. 36:505-512.
16. Morrone, R., G. Nicolosi, A. Patti, and M. Piattelli. 1995. Resolution of racemic flurbiprofen by lipasi-mediated esterification in organic solvent. Tetrahedron: Asymmetry. 6:1773-1778.
17. Morone, R., M. Piattelli, and G. Nicolosi. 2001. Resolution of racemic acids by irreversible lipasi-catalyzed esterification in organic solvent. Eur. J. Org. Chem. 8:1441-1443.
18. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:55-63.
19. 15N] nitrate in biological fluids. Anal. Biochem. 126:131-138.
20. Farndale, R. W., C. A. Sayers, and A. J. Barrett. 1989. A direct spectrophotometric microassay for sulphated glycosaminoglycans in cultured cartilage. Connect. Tissue Res. 2:247-248.
21. Stone, J. E., N. Akttar, S. Botchway, and C. A. Pennock. 1994. Interaction of 1,9-dimethylmethylene blue with glycosaminoglycans. Ann. Clin. Biochem. 31:147-152.
22. Renis, M., V. Cardile, M. Palumbo, and A. Russo. 2000. Et-18-OCH3-induced cytotoxicity and DNA damage in rat astrocytes. Int. J. Dev. Neurosci. 18:545-555.
23. Dinarello, C. A. 1992. Interleukin-1 and tumor necrosis factor: effector cytokines in autoimmune diseases. Semin. Immunol. 4:133-145.
24. Arend W. P., and J. M. Dayer. 1995. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum. 38:151-160.
25. Henrotin, Y. E., P. Bruckner, and J. P. Pujol. 2003. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthr. Cartil. 11:747-755.
26. Hitchon, C. A., and H. S. El-Gabalawy. 2004. Oxidation in rheumatoid arthritis. Arthritis Res. Ther. 6:265-278.
27. Little, C. B., C. R. Flannery, C. E. Hughes, A. Goodship, and B. Caterson. 2005. Cytokine induced metalloproteinase expression and activity does not correlate with focal susceptibility of articular cartilage to degeneration. Osteoarthr. Cartil. 13:162-170.